At the federal level, the Trump administration decided not to proceed with a Biden administration proposal to allow Medicare and require Medicaid to cover obesity drugs but recently launched their own obesity drug coverage initiatives to reduce costs and increase access (see Box 1)
Protease inhibitor co-formulations showed promise in preclinical models but raised safety concerns about chronic inhibition of digestive enzymes and were often ineffective against the full spectrum of proteases encountered along the gastrointestinal tract
Is PT-141 prescribed for men, women, or both
It eliminates exposure to preservatives while offering cost savings for high-volume single-use applications
For consumers, this matters because: Ingredient clarity is often linked to credibility
Biomarkers including fasting insulin, insulin resistance (HOMA-IR), and inflammatory markers (CRP) help providers understand whether plateau reflects metabolic adaptation, insufficient medication dosage, or lifestyle drift